Latin America Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.

Press releases published on April 24, 2026

Doula Catolica: acompañamiento integral para la concepción, el embarazo, parto y posparto desde la fe católica
OraPub Enhances Shane AI to Help Oracle Teams Diagnose Performance Problems Faster
Performance Lab Under Investigation: Premium-Grade Nutritional Supplements with Research-Backed Ingredients That Work
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Park Dental Partners Announces Dates for First Quarter 2026 Earnings Release and Conference Call
Crescent Biopharma Announces Grants of Inducement Awards
AEON Biopharma Sets Annual Shareholder Meeting
Intellia Therapeutics to Report Topline Data from Global Phase 3 HAELO Clinical Trial of Lonvoguran Ziclumeran in Hereditary Angioedema on April 27, 2026
Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer
FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim
ForLife and Oakmed Ltd. to Become Unora GmbH and Unora Healthcare Ltd Effective May 1, 2026
Biotech startup Plopii Files US Patent on the Next-Generation Headache Pill
Press Release: Sanofi successfully prices 2.3 billion of bond issue
Communiqué de presse : Sanofi place 2,3 milliard d’euros d’emprunts obligataires
RTA Outdoor Living Launches 'Health Haven' YouTube Special on Backyard Design and Health
Metabo Drops 2026 | Launch "Tasteless Drop Effective Weight Loss Turns Any Coffee Into Boosted Metabolism Explained Fat Burning Supplement MetaboDrops
KFSH Scales Genomic Medicine from Research to Clinical Decision-Making
Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder
DNA DAY™ 2026: GeneLife Advances GeneAI Forecast with 15 Predictive Models and Enhanced Lifestyle Integration

Share this page:

Sign up for:

Latin America Health Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.